Portable Artificial Pancreas Applied for Youth and Adolescents

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 28, 2022

Primary Completion Date

May 19, 2023

Study Completion Date

May 19, 2023

Conditions
Diabetes Mellitus, Type 1
Interventions
DEVICE

Bi-hormonal closed-loop control

During bi-hormonal closed-loop control insulin and glucagon are administered to the developed closed-loop algorithm. Aditionally, patients will wear a blinded Dexcom G6 for data collection during the closed loop period.

DEVICE

Open-loop control

During open-loop control the patients will use their usual diabetes therapy. Aditionally, patients will wear a blinded Dexcom G6 for data collection during the open loop period.

Trial Locations (1)

6815 AD

Rijnstate Ziekenhuis, Arnhem

Sponsors
All Listed Sponsors
collaborator

Stichting Robopump

UNKNOWN

collaborator

Rijnstate ziekenhuis

UNKNOWN

collaborator

Kinder Diabetes Centrum Nijmegen

UNKNOWN

lead

Inreda Diabetic B.V.

INDUSTRY